SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-016984
Filing Date
2023-06-08
Accepted
2023-06-08 16:27:00
Documents
19
Period of Report
2023-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20230608_8k.htm   iXBRL 8-K 33848
2 EXHIBIT 1.1 ex_531250.htm EX-1.1 279480
3 EXHIBIT 5.1 ex_531434.htm EX-5.1 7071
4 EXHIBIT 99.1 ex_531251.htm EX-99.1 13558
5 EXHIBIT 99.2 ex_531252.htm EX-99.2 14001
10 footer.jpg GRAPHIC 9921
11 header.jpg GRAPHIC 10598
  Complete submission text file 0001437749-23-016984.txt   589496

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20230606.xsd EX-101.SCH 3600
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20230606_def.xml EX-101.DEF 11531
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20230606_lab.xml EX-101.LAB 15413
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20230606_pre.xml EX-101.PRE 11687
13 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20230608_8k_htm.xml XML 2558
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 231002261
SIC: 2836 Biological Products, (No Diagnostic Substances)